Atrium Therapeutics Inc

Atrium Therapeutics Inc(RNA)價格預測

$8.320

-0.345 (-4.15%)收盤時

價格預測

1-Day Price Prediction
+0.57%
1-Week Prediction
-0.34%
1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

RNA 相似圖表分析預測

Alphio's RNA stock price prediction model matches the current Atrium Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.37 (+0.57%). The 1-week path is $8.29 (-0.34%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 Atrium Therapeutics Inc 股票嗎?

Avidity Biosciences Inc (RNA) is a good buy right now due to its current price of $8.55, which is significantly below its 52-week high of $73.06, indicating substantial upside potential. The RSI of 70.53 suggests that the stock is currently overbought, but the recent 5-day change of +6.21% and a strong upcoming clinical trial could drive further interest. However, the main risk is the significant insider selling, which has increased by 200.63% over the last month, indicating potential concerns about future performance.

RNA 股價於 Thursday 收在 $8.32,此前下跌 -4.15%

Atrium Therapeutics Inc (RNA) last closed at $8.3199997, losing -4.15%. These facts feed the 1-day and 1-week RNA price prediction above.

預測驅動因素

Atrium Therapeutics Inc(RNA)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。

Similar patterns

Positive

Bullish

Seasonality

Positive

Bullish

SMA 20

Positive

Bullish

SMA 200

Negative

Bearish

相似圖表形態

近期走勢與 RNA 最接近的股票,依相似度排序。

RNA 季節性分析

Historically the probability of a positive November return for RNA is 90.70%. December offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易